Literature DB >> 18398010

A review of Parkinson's disease.

C A Davie1.   

Abstract

INTRODUCTION: Parkinson's disease (PD) is one of the most common neurodegenerative disorders. Sources of data Literature search using Medline with keywords Parkinson's disease supplemented with previously published papers known to the author. AREAS OF AGREEMENT: There have been significant recent advances in the understanding of the pathogenesis of the disease. There has also been a greater realization that the disorder may be associated with significant non-motor disturbances in addition to the more commonly recognized motor complications. AREAS OF CONTROVERSY: Although there is growing circumstantial evidence, it remains to be proven whether any of the current treatments for PD have a neuroprotective effect. AREAS TIMELY FOR DEVELOPING RESEARCH: Although there is no cure, there are several management options for the early treatment of PD. As the disease progresses, further treatment options are available; however, the management of late-stage motor complications and non-motor symptoms remains particularly challenging and will benefit from further clinical research.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18398010     DOI: 10.1093/bmb/ldn013

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  205 in total

1.  Roles of the M1 muscarinic acetylcholine receptor subtype in the regulation of basal ganglia function and implications for the treatment of Parkinson's disease.

Authors:  Zixiu Xiang; Analisa D Thompson; Carrie K Jones; Craig W Lindsley; P Jeffrey Conn
Journal:  J Pharmacol Exp Ther       Date:  2011-12-01       Impact factor: 4.030

Review 2.  Neurological disorders and the potential role for stem cells as a therapy.

Authors:  Paul R Sanberg; David J Eve; L Eduardo Cruz; Cesar V Borlongan
Journal:  Br Med Bull       Date:  2012-02-21       Impact factor: 4.291

3.  α6ß2* and α4ß2* nicotinic receptors both regulate dopamine signaling with increased nigrostriatal damage: relevance to Parkinson's disease.

Authors:  Xiomara A Perez; Tanuja Bordia; J Michael McIntosh; Maryka Quik
Journal:  Mol Pharmacol       Date:  2010-08-23       Impact factor: 4.436

Review 4.  Stem cell-based models and therapies for neurodegenerative diseases.

Authors:  Shilpa Iyer; Khaled Alsayegh; Sheena Abraham; Raj R Rao
Journal:  Crit Rev Biomed Eng       Date:  2009

5.  Computer-Aided Diagnosis of Parkinson's Disease Using Enhanced Probabilistic Neural Network.

Authors:  Thomas J Hirschauer; Hojjat Adeli; John A Buford
Journal:  J Med Syst       Date:  2015-09-29       Impact factor: 4.460

6.  Edaravone leads to proteome changes indicative of neuronal cell protection in response to oxidative stress.

Authors:  Mohammad-Saeid Jami; Zahra Salehi-Najafabadi; Fereshteh Ahmadinejad; Esthelle Hoedt; Morteza Hashemzadeh Chaleshtori; Mahdi Ghatrehsamani; Thomas A Neubert; Jan Petter Larsen; Simon Geir Møller
Journal:  Neurochem Int       Date:  2015-07-29       Impact factor: 3.921

7.  Saturation Binding of Nicotine to Synthetic Neuromelanin Demonstrated by Fluorescence Spectroscopy.

Authors:  Robert L Haining; Travis M Jones; Aubrey Hernandez
Journal:  Neurochem Res       Date:  2016-09-23       Impact factor: 3.996

Review 8.  Selective MAO-B inhibitors: a lesson from natural products.

Authors:  Simone Carradori; Melissa D'Ascenzio; Paola Chimenti; Daniela Secci; Adriana Bolasco
Journal:  Mol Divers       Date:  2013-11-12       Impact factor: 2.943

9.  Loss of PINK1 attenuates HIF-1α induction by preventing 4E-BP1-dependent switch in protein translation under hypoxia.

Authors:  William Lin; Natasha L Wadlington; Linan Chen; Xiaoxi Zhuang; James R Brorson; Un Jung Kang
Journal:  J Neurosci       Date:  2014-02-19       Impact factor: 6.167

Review 10.  Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases.

Authors:  Jinsha Liu; Joey Paolo Ting; Shams Al-Azzam; Yun Ding; Sepideh Afshar
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.